About BioD
BioD is a company based in Memphis (United States) founded in 2010 was acquired by Derma Sciences in July 2016. BioD operates in a competitive market with competitors including Humacyte, MediWound, CUTISS, QBiotics and ProFibrix, among others.
- Headquarter Memphis, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Derma Sciences
(Jul 28, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioD
Detailed funding history for BioD
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in BioD
BioD has secured backing from 1 investor. Prominent investors backing the company include Derma Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of tissue regeneration and wound care products
|
Locked | Locked | Locked |
Investor details for BioD
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioD
Investment portfolio details for BioD
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioD
Detailed financials for BioD
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biod Comparisons
Peer comparison for BioD
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioD
BioD operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Humacyte, MediWound, CUTISS, QBiotics and ProFibrix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Human tissue-based products are developed for vascular disease applications.
|
|
| Locked | Locked | Locked |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| Locked | Locked | Locked |
Personalized skin tissue therapy is developed by CUTISS for surgeries.
|
|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Powdered fibrin sealant for surgical bleeding
|
|
| Locked | Locked | Locked |
Developer of myocardial regenerative medicine for treating heart diseases
|
Detailed competitors of BioD
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biod
Complete news archive for BioD
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioD
BioD was founded in 2010.
BioD is headquartered in Memphis, United States. It is registered at Memphis, Tennessee, United States.
BioD is a vertically integrated biotechnology company engaged in the development and commercialization of novel biologic products derived from the placental tissues. Their research and development efforts are focused on the regenerative potential of amnion and the other placental tissues given their unique biologic structure, their rich source of undifferentiated stem cells, and the immune privilege that characterizes their function in the body. From the recovery of tissue from live, healthy donors during childbirth to the development of new products that improve patient outcomes, BioD is unlocking the regenerative potential of the human body. BioDs product portfolio consists of human placental tissue-derived allografts for a broad range of clinical applications, including the treatment of complex chronic wounds, acute wounds (for example, decubitus or pressure ulcers), and localized areas of injury or inflammation, in addition to filling soft tissue defects or voids.. The products are also used as a localized wound covering to minimize the formation of post-operative adhesions, as well as to cover or wrap the dura, nerves and tendons.
BioD's top competitors include Humacyte, CUTISS and Ilya Pharma.
BioD has 1 investor. Key investors include Derma Sciences.